- Home
- HOWL vs SIEB Comparison
HOWL vs SIEB Comparison
Compare HOWL & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- SIEB
- Stock Information
- Founded
- HOWL 2017
- SIEB 1886
- Country
- HOWL United States
- SIEB United States
- Employees
- HOWL N/A
- SIEB N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- SIEB Investment Bankers/Brokers/Service
- Sector
- HOWL Health Care
- SIEB Finance
- Exchange
- HOWL Nasdaq
- SIEB Nasdaq
- Market Cap
- HOWL 87.4M
- SIEB 94.9M
- IPO Year
- HOWL 2021
- SIEB N/A
- Fundamental
- Price
- HOWL $1.55
- SIEB $3.04
- Analyst Decision
- HOWL Strong Buy
- SIEB
- Analyst Count
- HOWL 2
- SIEB 0
- Target Price
- HOWL $13.50
- SIEB N/A
- AVG Volume (30 Days)
- HOWL 344.3K
- SIEB 42.1K
- Earning Date
- HOWL 11-07-2024
- SIEB 11-12-2024
- Dividend Yield
- HOWL N/A
- SIEB N/A
- EPS Growth
- HOWL N/A
- SIEB 61.43
- EPS
- HOWL N/A
- SIEB 0.27
- Revenue
- HOWL $3,386,000.00
- SIEB $83,357,000.00
- Revenue This Year
- HOWL N/A
- SIEB N/A
- Revenue Next Year
- HOWL $34.17
- SIEB N/A
- P/E Ratio
- HOWL N/A
- SIEB $11.40
- Revenue Growth
- HOWL N/A
- SIEB 27.81
- 52 Week Low
- HOWL $1.38
- SIEB $1.41
- 52 Week High
- HOWL $8.19
- SIEB $3.31
- Technical
- Relative Strength Index (RSI)
- HOWL 36.96
- SIEB 54.28
- Support Level
- HOWL $1.50
- SIEB $2.97
- Resistance Level
- HOWL $1.63
- SIEB $3.26
- Average True Range (ATR)
- HOWL 0.12
- SIEB 0.24
- MACD
- HOWL 0.00
- SIEB -0.02
- Stochastic Oscillator
- HOWL 30.09
- SIEB 54.24
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.